PreveCeutical Medical Inc. (PRVCF)
PreveCeutical Medical Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.01, up 19.78% on the session, giving a market capitalisation of $7.7M. On trailing twelve-month figures it carries a trailing P/E of -5.00, a net margin of 0.0%. Its beta of 0.07 implies it has historically moved less than the broad market.
Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The company's innovative pipeline includes a cannabinoid Sol-Gel Delivery system designed for nose-to-brain administration, offering potential relief for ailments such as pain, inflammation, seizures, and various neurological disorders. Other key initiatives involve the BSV Peptide Program, aimed at halting cancer progression; a non-addictive analgesic for effective pain management; and a Dual Gene Therapy addressing type 2 diabetes and obesity. Furthermore, PreveCeutical is developing a diverse array of medicinal products based on cannabis.
PreveCeutical Medical Inc. is most often compared with the following Healthcare names: